BTG plc’s (BTG) “Buy” Rating Reaffirmed at Numis Securities Ltd

Numis Securities Ltd restated their buy rating on shares of BTG plc (LON:BTG) in a research report released on Wednesday, Marketbeat reports. Numis Securities Ltd currently has a GBX 900 ($11.72) price target on the stock.

Receive News & Ratings for BTG plc Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.

BTG has been the topic of several other research reports. J P Morgan Chase & Co reiterated a neutral rating and issued a GBX 790 ($10.29) price target on shares of BTG plc in a report on Tuesday, July 4th. Deutsche Bank AG reiterated a buy rating and issued a GBX 775 ($10.09) price target on shares of BTG plc in a report on Thursday, May 18th. Panmure Gordon cut their price target on shares of BTG plc from GBX 809 ($10.54) to GBX 793 ($10.33) and set a buy rating on the stock in a report on Monday, May 22nd. Jefferies Group LLC reiterated a buy rating and issued a GBX 775 ($10.09) price target on shares of BTG plc in a report on Tuesday, May 16th. Finally, Peel Hunt restated a hold rating and issued a GBX 630 ($8.20) price objective on shares of BTG plc in a research report on Tuesday, May 16th. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. BTG plc presently has an average rating of Buy and a consensus price target of GBX 766.44 ($9.98).

BTG plc (LON:BTG) traded down 0.69% during trading on Wednesday, hitting GBX 643.50. 272,894 shares of the company were exchanged. The stock’s market capitalization is GBX 2.48 billion. The firm’s 50 day moving average price is GBX 672.62 and its 200-day moving average price is GBX 630.06. BTG plc has a 1-year low of GBX 528.36 and a 1-year high of GBX 738.50.

TRADEMARK VIOLATION WARNING: This article was published by [[site]] and is owned by of [[site]]. If you are viewing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this article can be viewed at [[permalink]].

In other BTG plc news, insider Rolf Soderstrom sold 129,514 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of GBX 655 ($8.53), for a total value of £848,316.70 ($1,104,722.88).

BTG plc Company Profile

BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.